Logo image of BCX

BLACKROCK RESOURCES & COMMOD (BCX) Stock Price, Quote, News and Overview

NYSE:BCX - New York Stock Exchange, Inc. - US09257A1088 - Currency: USD

9.75  +0.08 (+0.83%)

After market: 9.77 +0.02 (+0.21%)

Fundamental Rating

2

Taking everything into account, BCX scores 2 out of 10 in our fundamental rating. BCX was compared to 0 industry peers in the Unkown industry. While BCX seems to be doing ok healthwise, there are quite some concerns on its profitability. BCX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BCX had negative earnings in the past year.
In the past year BCX had a positive cash flow from operations.
In multiple years BCX reported negative net income over the last 5 years.
In the past 5 years BCX always reported a positive cash flow from operatings.
BCX Yearly Net Income VS EBIT VS OCF VS FCFBCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -2.97%
ROE -3.03%
ROIC 1.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCX Yearly ROA, ROE, ROICBCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

BCX's Operating Margin has declined in the last couple of years.
BCX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 66.14%
PM (TTM) N/A
GM 68.86%
OM growth 3Y-4.61%
OM growth 5Y-1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.02%
GM growth 5Y-0.98%
BCX Yearly Profit, Operating, Gross MarginsBCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

More info and screens

5

2. Health

2.1 Basic Checks

BCX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BCX Yearly Shares OutstandingBCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
BCX Yearly Total Debt VS Total AssetsBCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 26.59 indicates that BCX is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BCX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 26.59
ROIC/WACCN/A
WACCN/A
BCX Yearly LT Debt VS Equity VS FCFBCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.40 indicates that BCX should not have too much problems paying its short term obligations.
BCX has a Quick Ratio of 1.40. This is a normal value and indicates that BCX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
BCX Yearly Current Assets VS Current LiabilitesBCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

BCX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -311.11%.
The Revenue for BCX has decreased by -18.20% in the past year. This is quite bad
The Revenue has been decreasing by -1.64% on average over the past years.
EPS 1Y (TTM)-311.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-332%
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-7.21%
Revenue growth 5Y-1.64%
Sales Q2Q%-22.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BCX Yearly Revenue VS EstimatesBCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BCX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCX Price Earnings VS Forward Price EarningsBCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 7.94
EV/EBITDA N/A
BCX Per share dataBCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

BCX has a Yearly Dividend Yield of 7.94%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.42, BCX pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.94%

5.2 History

The dividend of BCX has a limited annual growth rate of 0.27%.
BCX has paid a dividend for at least 10 years, which is a reliable track record.
BCX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.27%
Div Incr Years3
Div Non Decr Years3
BCX Yearly Dividends per shareBCX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BCX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-196.3%
EPS Next 2YN/A
EPS Next 3YN/A
BCX Yearly Income VS Free CF VS DividendBCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

More info and screens

BLACKROCK RESOURCES & COMMOD

NYSE:BCX (7/3/2025, 7:04:14 PM)

After market: 9.77 +0.02 (+0.21%)

9.75

+0.08 (+0.83%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners32.9%
Inst Owner Change-9.03%
Ins OwnersN/A
Ins Owner Change0%
Market Cap762.35M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 7.94%
Yearly Dividend0.63
Dividend Growth(5Y)0.27%
DP-196.3%
Div Incr Years3
Div Non Decr Years3
Ex-Date06-13 2025-06-13 (0.0697)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.23
P/FCF 7.94
P/OCF 7.94
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.23
FCFY12.59%
OCF(TTM)1.23
OCFY12.59%
SpS0.36
BVpS11.41
TBVpS11.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -3.03%
ROCE 2.04%
ROIC 1.61%
ROICexc 1.61%
ROICexgc 1.61%
OM 66.14%
PM (TTM) N/A
GM 68.86%
FCFM 342.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.61%
OM growth 5Y-1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.02%
GM growth 5Y-0.98%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 26.59
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-311.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-332%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-7.21%
Revenue growth 5Y-1.64%
Sales Q2Q%-22.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.93%
EBIT growth 3Y-11.49%
EBIT growth 5Y-3.22%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.29%
FCF growth 3Y30.81%
FCF growth 5Y2.41%
OCF growth 1Y14.29%
OCF growth 3Y30.81%
OCF growth 5Y2.41%